Author:
Bruera Sebastian,Carmona Loreto,Lopez-Olivo Maria A.,Westrich-Robertson Tiffany,March Lyn,Negron Jose B,Christensen Robin,Strand Vibeke,Ingegnoli Francesca,Goel Niti,Shea Beverley,Tugwell Peter,Leong Amye,Bingham Clifton O.,Hill Catherine L.,Suarez-Almazor Maria E.
Funder
Parker Institute for Cancer Immunotherapy
Eli Lilly and Company
Pfizer
Oak Foundation
AbbVie
Subject
Anesthesiology and Pain Medicine,Rheumatology
Reference14 articles.
1. OMERACT: Outcome Measures in Rheumatology. http://www.omeract.org.
2. Outcome measures and classification criteria for the rheumatic diseases. A compilation of data from OMERACT (Outcome Measures for Arthritis Clinical Trials), ILAR (International League of Associations for Rheumatology), regional leagues and other groups;Brooks;Rheumatology (Oxford),2001
3. World Health Organization and international league of associations for rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials;Boers;J Rheumatol,1994
4. Improving the reporting of pragmatic trials: an extension of the CONSORT statement;Zwarenstein;BMJ,2008
5. Issues relating to study design and risk of bias when including non-randomized studies in systematic reviews on the effects of interventions;Higgins;Res Synth Methods,2013
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献